| Completed | Clinical Trial of Efepoetin Alfa in Healthy Subjects Healthy | Phase 1 | 2024-10-29 |
| Recruiting | A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis Anemia of Chronic Kidney Disease | Phase 3 | 2024-01-25 |
| Unknown | GX-I7 in Combination With Bevacizumab in Recurrent Glioblastoma (GBM) Patients Recurrent Glioblastoma | Phase 2 | 2022-01-26 |
| Withdrawn | Evaluation of Efficacy, Safety and Immunogenicity of GX-19N in Healthy Individuals Who Have Received COVID-19 SARS-CoV2 Infection | Phase 2 / Phase 3 | 2021-10-01 |
| Terminated | Safety and Preliminary Efficacy Study of GX-I7 in Patients With COVID-19 Covid19 | Phase 1 | 2021-03-24 |
| Completed | Safety and Immunogenicity of GX-19N, a COVID-19 Preventive DNA Vaccine in Elderly Individuals SARS-CoV-2 | Phase 1 | 2021-02-16 |
| Completed | Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults SARS-CoV-2 | Phase 1 / Phase 2 | 2020-12-30 |
| Completed | Safety and Tolerability of GX-P1 in Healthy Male Volunteers Autoimmune Diseases | Phase 1 | 2020-08-11 |
| Terminated | Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults SARS-CoV-2 | Phase 1 / Phase 2 | 2020-06-17 |
| Withdrawn | Efficacy and Safety Study of GX-I7 Plus Adjuvant Temozolomide Combination in Patients With Newly Diagnosed Gli Newly Diagnosed Glioblastoma | Phase 1 / Phase 2 | 2019-08-22 |
| Unknown | A Phase 2, 12-Week, Double-Blind, Efficacy and Safety of GX-G6 in Patients With Uncontrolled Type 2 Diabetes M Type 2 Diabetes Mellitus | Phase 2 | 2019-06-01 |
| Completed | Study of GX-I7 in Combination With Pembrolizumab in Refractory or Relapsed (R/R) TNBC Subjects(GX-I7-CA-006/KE Triple Negative Breast Cancer | Phase 1 / Phase 2 | 2019-03-27 |
| Completed | GX-I7 With Cyclophosphamide in Patients With Metastatic or Recurrent Solid Tumors Solid Tumor | Phase 1 | 2018-10-17 |
| Completed | Dose-escalation Study to Evaluate the Safety and Tolerability of GX-I7 in Patients With Glioblastoma Newly Diagnosed Glioblastoma | Phase 1 | 2018-06-20 |
| Completed | The Combination of GX-188E Vaccination and Pembrolizumab in Patients With HPV 16 and/or 18+ Advanced Cervical Cervical Cancer | Phase 1 / Phase 2 | 2018-06-19 |
| Completed | Study to Evaluate Safety and Tolerability of GX-I7 in Patients With Locally Advanced or Metastatic Solid Tumor Locally Advanced or Metastatic Solid Tumors | Phase 1 | 2018-03-05 |
| Completed | Tolerability, Safety and Pharmacokinetics Study of GX-30 in Total Thyroidectomy or Near Total Thyroidectomy Pa Total Thyroidectomy, Near-total Thyroidectomy | Phase 1 / Phase 2 | 2017-09-07 |
| Completed | Safety and Tolerability of GX-G6 in Healthy Male Subjects Diabetes Mellitus | Phase 1 | 2017-08-31 |
| Completed | Safety and Tolerability of GX-I7 in HPV-infected Female Volunteers Human Papillomavirus | Phase 1 | 2017-02-16 |
| Completed | Clinical Trial of GX-I7 in Healthy Volunteers Healthy | Phase 1 | 2016-07-11 |
| Completed | Dose Finding Study of GX-H9 in Paeditaric Patients With Growth Hormone Deficiency Growth Hormone Deficiency | Phase 2 | 2016-01-18 |
| Unknown | Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Plasmid DNA Therapeutic Vaccine(GX-188E) Cervical Intraepithelial Neoplasia | Phase 2 | 2015-08-01 |
| Unknown | Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation Cervical Intraepithelial Neoplasia 3 | — | 2015-03-01 |
| Completed | A Clinical Study in AGHD to Assess Safety, Tolerability and Efficacy of GX-H9 Adult Growth Hormone Deficiency | Phase 2 | 2015-01-01 |
| Completed | Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of GX-E2 in Healthy Subjects Healthy | Phase 1 | 2014-11-01 |
| Completed | Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia Cervical Intraepithelial Neoplasia | Phase 2 | 2014-07-01 |
| Completed | Study to Evaluate the Efficacy and Safety of GX-E2 in the Anemic Patients Diagnosed With Chronic Kidney Diseas Anemia, Chronic Kidney Disease | Phase 2 | 2014-04-15 |
| Completed | Genetically Modified Mesenchymal Stem Cell Theraopeutic Against Head and Neck Cancer Head and Neck Cancer | Phase 1 | 2014-03-01 |
| Unknown | Safety and Efficacy of GX-188E DNA Therapeutic Vaccine Administered by Electroporation After Observation Cervical Intraepithelial Neoplasia 3 | — | 2014-02-01 |
| Completed | Phase I Study GX-G3 in Healthy Subjects Healthy | Phase 1 | 2013-09-01 |
| Completed | Study of the Immunogenicity and Efficacy of HBsAg Vaccine in Combination With Standard Antiviral Therapy With Chronic Hepatitis B | N/A | 2013-02-01 |
| Completed | Safety of GX-188E DNA Therapeutic Vaccine Administered by Electroporation to Cervical Intraepithelial Neoplasi Cervical Intraepithelial Neoplasia 3 | Phase 1 | 2012-11-01 |
| Completed | Tolerability, Immunogenicity and Efficacy of HB-110 Administered by Electroporation in Chronic Hepatitis B Pat Hepatitis B, Chronic | Phase 1 | 2011-11-01 |
| Completed | Phase I Study to Investigate the Safety and Efficacy of HBV DNA Vaccine Chronic Hepatitis B | Phase 1 | 2007-07-01 |
| Unknown | Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients HIV Infections | Phase 1 | 2006-08-01 |
| No Longer Available | Individual Patient Compassionate Use of GX-I7 Glioblastoma, High Grade Glioma, Recurrent Glioblastoma | — | — |